Science Explorer Back to mapMap

Most cited papers from Sterna Biologicals (Germany)

What are the most cited papers from Sterna Biologicals (Germany)?

The most cited paper from Sterna Biologicals (Germany) is "Allergen-Induced Asthmatic Responses Modified by a GATA3-Specific DNAzyme" (Norbert Krug et al., 2015), with 324 citations. Next come "Effective prevention and therapy of experimental allergic asthma using a GATA-3–specific DNAzyme" (106) and "Amphiphilic Biodegradable PEG-PCL-PEI Triblock Copolymers for FRET-Capable in Vitro and in Vivo Delivery of siRNA and Quantum Dots" (88).

Showing 25 of 25 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Allergen-Induced Asthmatic Responses Modified by a GATA3-Specific DNAzyme Norbert Krug et al. · New England Journal of Medicine Open access 17 May 2015 324
2 Effective prevention and therapy of experimental allergic asthma using a GATA-3–specific DNAzyme Serdar Sel, Michael Wegmann, Tanja Dicke et al. · Journal of Allergy and Clinical Immunology 7 Mar 2008 106
3 Amphiphilic Biodegradable PEG-PCL-PEI Triblock Copolymers for FRET-Capable in Vitro and in Vivo Delivery of siRNA and Quantum Dots Thomas Endres, Mengyao Zheng, Ayşe Kılıç et al. · Molecular Pharmaceutics 4 Mar 2014 88
4 Development of multiple W/O/W emulsions as dermal carrier system for oligonucleotides: Effect of additives on emulsion stability Thomas Schmidts, Dorota Dobler, Peggy Schlupp et al. · International Journal of Pharmaceutics 3 Aug 2010 78
5 Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice Vanessa Popp, Katharina Gerlach, Stefanie Mott et al. · Gastroenterology 15 Sep 2016 74
6 Safety and tolerability of a novel inhaled GATA3 mRNA targeting DNAzyme in patients with TH2-driven asthma Ursula Homburg, Harald Renz, Wolfgang Timmer et al. · Journal of Allergy and Clinical Immunology 5 Apr 2015 49
7 A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial Timm Greulich, Jens Michael Hohlfeld, Petra Neuser et al. · Respiratory Research Open access 4 Apr 2018 38
8 Biodistribution of the GATA-3-specific DNAzyme hgd40 after inhalative exposure in mice, rats and dogs Agnieszka M. Turowska, Damiano Librizzi, Nadja Baumgartl et al. · Toxicology and Applied Pharmacology 29 Jun 2013 26
9 Protective effect of drug delivery systems against the enzymatic degradation of dermally applied DNAzyme Thomas Schmidts, Dorota Dobler, Sylvia von den Hoff et al. · International Journal of Pharmaceutics 2 Apr 2011 25
10 Clinical Expert Panel on Monitoring Potential Lung Toxicity of Inhaled Oligonucleotides: Consensus Points and Recommendations Eric W.F.W. Alton, Homer A. Boushey, Holger Garn et al. · Nucleic Acid Therapeutics Open access 18 Jul 2012 25
11 Development of drug delivery systems for the dermal application of therapeutic DNAzymes Thomas Schmidts, Kay Marquardt, Peggy Schlupp et al. · International Journal of Pharmaceutics 15 Apr 2012 23
12 Toxicity profile of the GATA-3-specific DNAzyme hgd40 after inhalation exposure Rainer Fuhst, Frank E. Runge, Jochen Buschmann et al. · Pulmonary Pharmacology & Therapeutics 20 Dec 2012 20
13 Absence of Unspecific Innate Immune Cell Activation by GATA-3-Specific DNAzymes Tanja Dicke, Isabella Pali‐Schöll, Andreas Martin Kaufmann et al. · Nucleic Acid Therapeutics Apr 2012 19
14 Blood eosinophils predict therapeutic effects of a GATA3-specific DNAzyme in asthma patients Norbert Krug, Jens Michael Hohlfeld, Roland Buhl et al. · Journal of Allergy and Clinical Immunology Open access 22 Mar 2017 18
15 Flow Cytometry-Based Cell Type-Specific Assessment of Target Regulation by Pulmonary siRNA Delivery Olivia M. Merkel, Leigh Matthew Marsh, Holger Garn et al. · Methods in molecular biology Book chapterOpen access 14 Sep 2012 8
16 Efficacy of T-cell transcription factor–specific DNAzymes in murine skin inflammation models Ulrich Purath, Rouba Ibrahim, Jana Zeitvogel et al. · Journal of Allergy and Clinical Immunology 10 Nov 2015 7
17 Effects of interference with GATA‐3 expression by target‐specific DNAzyme treatment on disease progression in a subacute oxazolone‐induced mouse model of atopic dermatitis Rouba Ibrahim, Ulrich Purath, Agnieszka M. Turowska et al. · Clinical and Translational Allergy Open access 11 Mar 2015 3
18 Praetextatus – Verteidiger des römischen Glaubens? Zur gesellschaftlichen (Neu-)Inszenierung römischer Religion in Macrobius' Saturnalien Christa Frateantonio · Zeitschrift für Antikes Christentum / Journal of Ancient Christianity 10 Aug 2007 2
19 Der TH1 Transkriptionsfaktor T-bet als neues Target für die Morbus Crohn Therapie Vanessa Popp, Katharina Gerlach, Agnieszka M. Turowska et al. · Zeitschrift für Gastroenterologie 9 May 2017 1
20 Preclinical and Early Clinical Development of a GATA-3-Specific Dnazyme Intended for the Treatment of Th2-Driven Asthma Agnieszka M. Turowska, Ursula Homburg, Jens Kuhlmann et al. · Journal of Allergy and Clinical Immunology Open access 26 Jan 2013 1
21 Targeting the transcription factor GATA3 by the DNAzyme formulation SB012 in patients with moderately-to-severely active ulcerative colitis: a multicenter, randomized, placebo-controlled, phase 2a induction trial Raja Atreya, Tanja Kühbacher, Michael Vieth et al. · Inflammatory Bowel Diseases 9 May 2026 0
22 Impact of a Digital Inhalation Coach on Inhalation Errors and Asthma Control Laura J. Arendsen, Kai M. Beeh, Philipp Kroneberg et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery 16 Dec 2025 0
23 Influence of cigarette-smoke extract conditioned medium on CD4+ T cell differentiation in vitro Nadja Baumgartl, Agnieszka M. Turowska, Holger Garn · Pneumologie 11 Feb 2014 0
24 Distribution and efficacy of a GATA-3-specific DNAzyme in experimental allergic asthma models Agnieszka M. Turowska, Tanja Dicke, Nadja Baumgartl et al. · Pneumologie 31 May 2012 0
25 Autoimmune induction of a COPD-like inflammatory phenotype in mice Nadja Baumgartl, A Turowska, N Weißmann et al. · Pneumologie 31 May 2012 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.